Menlo Therapeutics Inc (MNLO.OQ)
MNLO.OQ on NASDAQ Stock Exchange Global Select Market
11.37USD
21 Sep 2018
11.37USD
21 Sep 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$11.37
$11.37
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
39,556
39,556
52-wk High
$38.68
$38.68
52-wk Low
$6.99
$6.99
Select another date:
Wed, May 9 2018
BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72
* MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
BRIEF-Menlo Therapeutics Says Japanese Phase 2 Trial Of Serlopitant Halted
* MENLO THERAPEUTICS - CO'S PARTNERS FOR COMMERCIALIZATION OF SERLOPITANT IN JAPAN, INFORMED DECISION TO HALT JAPANESE PHASE 2 CLINICAL TRIAL OF SERLOPITANT
BRIEF-Menlo Therapeutics Reports Q4 Loss Of $1.80 Per Share
* MENLO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
Select another date:
- Stocks To Watch: FANGs Out In Tech
- Menlo Crashes On Failed Phase 2 Atopic Dermatitis Study, A Great Buying Opportunity?
- U.S. IPO Weekly Recap: Another Unicorn Takes Flight As Zuora Pops +47%
- Your Daily Pharma Scoop: Acadia Sell-Off, Therapix Soars On Results, Menlo Setback
- Big Biotech Swings: 2016 IPO AveXis Pops 82%, 2018 IPO Menlo Drops 77%
- Biotechs Take The Podium With The Year's 3 Best IPOs